title: A randomized trial comparing the efficacy of OKT3 used to prevent or to treat rejection.
authors.affiliation: Transplantation Unit, Necker Hospital, Paris, France.
authors.forename: H
authors.initials: H
authors.lastname: Kreis
authors.forename: N
authors.initials: N
authors.lastname: Chkoff
authors.forename: L
authors.initials: L
authors.lastname: Chatenoud
authors.forename: A
authors.initials: A
authors.lastname: Debure
authors.forename: M
authors.initials: M
authors.lastname: Lacombe
authors.forename: Y
authors.initials: Y
authors.lastname: Chrétien
authors.forename: C
authors.initials: C
authors.lastname: Legendre
authors.forename: S
authors.initials: S
authors.lastname: Caillat
authors.forename: J F
authors.initials: JF
authors.lastname: Bach
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D006084:Graft Rejection; D006085:Graft Survival; D006801:Humans; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation; D008875:Middle Aged; D011897:Random Allocation
chemical_list: D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents